174156-45-7

Upstream product

• 174156-39-9 (E)-(2R,4R,6S)-6-(tert-Butyl-dimethyl-silanyloxy)-8-ethyl-2,4-dimethyl-deca-7,9-dienal 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 143680-14-2 (2R, 4R)-1-<(tert-Butyldimethylsilyl)oxy>-2,4-dimethylpentan-5-ol 
• 174156-37-7 (E)-3-Ethyl-penta-2,4-dienal 
• 174156-38-8 ((2R,4R)-5-Bromo-2,4-dimethyl-pentyloxy)-tert-butyl-dimethyl-silane 
• 174291-62-4 (E)-(5S,7R,9R)-10-(tert-Butyl-dimethyl-silanyloxy)-3-ethyl-7,9-dimethyl-deca-1,3-dien-5-ol 
• 174156-41-3 (E)-(2R,3S,6S,7R)-7-(tert-Butyl-diphenyl-silanyloxy)-3-(4-methoxy-benzyloxy)-2,6-dimethyl-oct-4-enoic acid methyl ester 
• 697751-91-0 (E)-(4S,5R)-5-(tert-Butyl-diphenyl-silanyloxy)-4-methyl-hex-2-en-1-ol 
• 174156-40-2 (E)-(4S,5R)-5-(tert-Butyl-diphenyl-silanyloxy)-4-methyl-hex-2-enal 
• 697751-93-2 (2R,3R)-3-(tert-butyldiphenylsilyloxy)-2-methylbutanal 

Relevant academic research and scientific papers

Determination of the C-7,9,12,13,17 and 18 stereochemistries of tautomycetin. Synthesis of the tautomycetin degradation product

Syntheses of the degradation product 3 of tautomycetin (1) and its diastereoisomers have been achieved. Comparison of the spectral data of these diastereoisomers with those of the degradation product of natural 1 indicates that tautomycetin has the 7R,9S,12S,13S,17S,18R stereochemistry.